• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

线粒体功能障碍与阿尔茨海默病。

Mitochondrial dysfunction and Alzheimer's disease.

机构信息

Department of Neurodegenerative Disorders, Mossakowski Medical Research Centre, Polish Academy of Sciences, Pawińskiego 5 Str., 02-106 Warszawa, Poland.

出版信息

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):320-30. doi: 10.1016/j.pnpbp.2010.07.004. Epub 2010 Jul 16.

DOI:10.1016/j.pnpbp.2010.07.004
PMID:20624441
Abstract

To date, one of the most discussed hypotheses for Alzheimer's disease (AD) etiology implicates mitochondrial dysfunction and oxidative stress as one of the primary events in the course of AD. In this review we focus on the role of mitochondria and mitochondrial DNA (mtDNA) variation in AD and discuss the rationale for the involvement of mitochondrial abnormalities in AD pathology. We summarize the current data regarding the proteins involved in mitochondrial function and pathology observed in AD, and discuss the role of somatic mutations and mitochondrial haplogroups in AD development.

摘要

迄今为止,阿尔茨海默病(AD)病因学中最受关注的假说之一是线粒体功能障碍和氧化应激是 AD 病程中的主要事件之一。在这篇综述中,我们重点关注线粒体和线粒体 DNA(mtDNA)变异在 AD 中的作用,并讨论了线粒体异常参与 AD 病理的原理。我们总结了目前关于 AD 中观察到的与线粒体功能和病理学相关的蛋白质的相关数据,并讨论了体细胞突变和线粒体单倍群在 AD 发病机制中的作用。

相似文献

1
Mitochondrial dysfunction and Alzheimer's disease.线粒体功能障碍与阿尔茨海默病。
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):320-30. doi: 10.1016/j.pnpbp.2010.07.004. Epub 2010 Jul 16.
2
Mitochondrial DNA variants in a Japanese population of patients with Alzheimer's disease.日本阿尔茨海默病患者群体中线粒体 DNA 变异。
Mitochondrion. 2010 Jan;10(1):32-7. doi: 10.1016/j.mito.2009.08.008. Epub 2009 Aug 22.
3
Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease.动脉粥样硬化性灌注不足脑微血管中的线粒体DNA缺失作为阿尔茨海默病发展的主要靶点。
J Neurol Sci. 2005 Mar 15;229-230:285-92. doi: 10.1016/j.jns.2004.11.040. Epub 2004 Dec 23.
4
Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.线粒体与血管病变作为转基因小鼠中阿尔茨海默病及阿尔茨海默病样病理发展的核心靶点。
Neurol Res. 2003 Sep;25(6):665-74. doi: 10.1179/016164103101201977.
5
Molecular Basis of Alzheimer's Disease: Focus on Mitochondria.阿尔茨海默病的分子基础:聚焦于线粒体。
J Alzheimers Dis. 2019;72(s1):S95-S116. doi: 10.3233/JAD-190048.
6
Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease.淀粉样前体蛋白与阿尔茨海默病中的线粒体功能障碍
Neuroscientist. 2007 Dec;13(6):626-38. doi: 10.1177/1073858407303536. Epub 2007 Oct 2.
7
Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.线粒体淀粉样β水平与不同脑区线粒体功能障碍的程度以及阿尔茨海默病转基因小鼠认知障碍的严重程度相关。
J Alzheimers Dis. 2010;20 Suppl 2:S535-50. doi: 10.3233/JAD-2010-100342.
8
Mitochondria, mitochondrial DNA and Alzheimer's disease. What comes first?线粒体、线粒体DNA与阿尔茨海默病。何者为先?
Curr Alzheimer Res. 2008 Oct;5(5):457-68. doi: 10.2174/156720508785908946.
9
Role of mitochondrial dysfunction in Alzheimer's disease.线粒体功能障碍在阿尔茨海默病中的作用。
J Neurosci Res. 2002 Nov 1;70(3):357-60. doi: 10.1002/jnr.10389.
10
Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.淀粉样前体蛋白介导的自由基与氧化损伤:对阿尔茨海默病发生发展的影响
J Neurochem. 2006 Jan;96(1):1-13. doi: 10.1111/j.1471-4159.2005.03530.x. Epub 2005 Nov 23.

引用本文的文献

1
Unveiling the role of local metabolic constraints on the structure and activity of spiking neural networks.揭示局部代谢限制对脉冲神经网络结构和活动的作用。
PLoS Comput Biol. 2025 Jun 13;21(6):e1013148. doi: 10.1371/journal.pcbi.1013148. eCollection 2025 Jun.
2
Newer Therapeutic Approaches in Treating Alzheimer's Disease: A Comprehensive Review.治疗阿尔茨海默病的新型治疗方法:综述
ACS Omega. 2025 Feb 3;10(6):5148-5171. doi: 10.1021/acsomega.4c05527. eCollection 2025 Feb 18.
3
Signaling Pathways Concerning Mitochondrial Dysfunction: Implications in Neurodegeneration and Possible Molecular Targets.
与线粒体功能障碍相关的信号通路:在神经退行性变中的意义及可能的分子靶点。
J Mol Neurosci. 2024 Oct 28;74(4):101. doi: 10.1007/s12031-024-02269-5.
4
Single-nucleus RNA velocity reveals critical synaptic and cell-cycle dysregulations in neuropathologically confirmed Alzheimer's disease.单细胞 RNA 速度揭示了神经病理学确诊的阿尔茨海默病中关键的突触和细胞周期失调。
Sci Rep. 2024 Mar 27;14(1):7269. doi: 10.1038/s41598-024-57918-x.
5
Quercetin-1,2,3-Triazole Hybrids as Multifunctional Anti-Alzheimer's Agents.槲皮素-1,2,3-三唑杂合体作为多功能抗阿尔茨海默病药物。
Molecules. 2023 Nov 9;28(22):7495. doi: 10.3390/molecules28227495.
6
Necroptosis and Alzheimer's Disease: Pathogenic Mechanisms and Therapeutic Opportunities.细胞坏死性凋亡与阿尔茨海默病:发病机制与治疗新机遇
J Alzheimers Dis. 2023;94(s1):S367-S386. doi: 10.3233/JAD-220809.
7
Expanding Arsenal against Neurodegenerative Diseases Using Quercetin Based Nanoformulations: Breakthroughs and Bottlenecks.利用槲皮素纳米制剂对抗神经退行性疾病的武器库不断扩大:突破与瓶颈。
Curr Neuropharmacol. 2023;21(7):1558-1574. doi: 10.2174/1570159X20666220810105421.
8
Characterization of Early Alzheimer's Disease-Like Pathological Alterations in Non-Human Primates with Aging: A Pilot Study.用衰老的非人类灵长类动物模型来描绘早期阿尔茨海默病样的病理改变:一项初步研究。
J Alzheimers Dis. 2022;88(3):957-970. doi: 10.3233/JAD-215303.
9
Targeted Metabolomic Analysis in Alzheimer's Disease Plasma and Brain Tissue in Non-Hispanic Whites.阿尔茨海默病患者血浆和脑组织中靶向代谢组学分析。
J Alzheimers Dis. 2022;86(4):1875-1895. doi: 10.3233/JAD-215448.
10
Effects of DISC1 on Alzheimer's disease cell models assessed by iTRAQ proteomics analysis.应用 iTRAQ 蛋白质组学分析探讨 DISC1 对阿尔茨海默病细胞模型的影响。
Biosci Rep. 2022 Jan 28;42(1). doi: 10.1042/BSR20211150.